Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
J Interv Card Electrophysiol ; 63(1): 49-58, 2022 Jan.
Article in English | MEDLINE | ID: mdl-33512606

ABSTRACT

PURPOSE: Experimental data suggest that shifts in the site of origin of the sinus node (SN) correlate with changes in heart rate and P wave morphology. The direct visualization of the effect of respiration on SN electrical activation has not yet been reported in humans. We aimed to measure the respiratory shifting of the SN activation using ultra-high-density mapping. METHODS: Sequential right atrial (RA) activation mapping during sinus rhythm (SR) was performed. Three maps were acquired for each patient: basal end-expiratory (Ex), end-inspiratory (Ins), and end-expiratory under isoproterenol (Iso). The earliest activation site (EAS) was defined as the earliest unipolar electrograms (EGM) with a QS pattern and was localized with respect to the ostium of the superior vena cava (SVC; negative values if EAS inside the SVC). RESULTS: In 20 patients, 49 maps in SR were acquired (20 Ex, 19 Ins, and 10 Iso). Expiratory (944 ± 227 ms) and inspiratory (946 ± 227 ms) SR cycle lengths were similar, but shortened under isoproterenol (752 ± 302 ms). Activation was unicentric in 33 maps and multicentric in 16: 4 during Ins, 10 during Ex, and 2 Iso. EAS location was significantly more cranial in expiration than in inspiration (0.27 ± 12.1 vs 5 ± 11.51 mm, p = 0.01). Iso infusion tends to induce a supplemental cranial shift (-4.07 ± 15.83 vs 0.27 ± 12.7 mm, p = 0.21). EAS were found in SVC in 22.7% of maps (30% Ex, 21% Ins, and 8% Iso). CONCLUSION: Inspiration induces a significant caudal shift of the earliest sinus activation. In one-third of the cases, sinus rhythm earliest activation is inside the SVC.


Subject(s)
Atrial Appendage , Atrial Fibrillation , Heart Atria , Heart Rate , Humans , Sinoatrial Node , Vena Cava, Superior
2.
Ann Cardiol Angeiol (Paris) ; 71(2): 78-85, 2022 Apr.
Article in French | MEDLINE | ID: mdl-33642050

ABSTRACT

Cardiac events recorders have been developed in order to record the heart rhythm during symptoms such as palpitations or presyncope, to first make a diagnosis, and subsequently drive the treatment strategy. In other circumstances, they can be also used in asymptomatic patients (to record silent atrial fibrillation for instance). Because they are non-invasive, potentially cost-saving and relatively easy to use, the external rhythm recording devices have shown some great advances in the last years, spreading from photoplethysmographic technique to real ECG reconstruction. Technological advances in the field of microelectronics, as well as in the field of data transmission have contributed to their widespread use in cardiology. The trend for miniaturization was also expanded to the implantable recorders. This paper will review will review advantages and limitations of the different existing available well-established recording devices, as well as the last technological developments in terms of ECG recordings.


Subject(s)
Atrial Fibrillation , Cardiology , Atrial Fibrillation/diagnosis , Electrocardiography, Ambulatory , Humans , Syncope
3.
Ann Cardiol Angeiol (Paris) ; 70(2): 68-74, 2021 Apr.
Article in French | MEDLINE | ID: mdl-33642047

ABSTRACT

BACKGROUND: Complete atrioventricular block (AVB3) may be an urgent potentially lifethreatening situation. Our objective was to describe the routine management of AVB 3, with emphasis on the organizational aspects. METHODS: From September 2019 to November 2019, a prospective national survey including 28 questions was electronically sent to 100 physicians (Google Form). RESULTS: The answers were collected from 93 physicians (response rate 93%). Permanent pacemaker implantation during weekends and nights (after 8PM) is possible for 49% of the operators (<5 times a year), for 15% (>5 times a year), impossible for 36% of the operators. For AVB3 nonresponsive to isoproterenol occurring during the night, a temporary pacing lead (TPL) is implanted by: the on-site medical staff on-duty (27%), the on-call interventional cardiologist (21%), the on-call electrophysiologist (19%), a permanent pacemaker is implanted by the electrophysiologist (12%), the strategy is not standardized (15%). An externalized active fixation lead (AFL) for AVB3 has already been implanted by 50% of the operators. 80 (86%) have already observed a dislocation of the TPL, a cardiac perforation already occurred in 57 (61%), a groin hematoma in 35 (38%), and this technique was proscribed for 4% of the operators. CONCLUSION: Our survey shows important disparities in terms of management of AVB3 among the different centers. An externalized AFL with a reusable generator was used by half of the centers.


Subject(s)
After-Hours Care/organization & administration , Atrioventricular Block/therapy , Health Care Surveys , Pacemaker, Artificial , Adult , After-Hours Care/statistics & numerical data , Aged , Algeria , Cardiotonic Agents/therapeutic use , Drug Resistance , France , Heart Injuries/epidemiology , Hematoma/epidemiology , Humans , Isoproterenol/therapeutic use , Mali , Middle Aged , Monaco , Morocco , Pacemaker, Artificial/adverse effects , Prospective Studies , Prosthesis Implantation/adverse effects , Prosthesis Implantation/methods , Tunisia
4.
Ann Cardiol Angeiol (Paris) ; 66(5): 323-325, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29029776

ABSTRACT

A 12 year-old boy, with no history of cardiac disease, was referred to our department for evaluation of an incessant accelerated idioventricular rhythm (AIVR) complicated with severe left ventricular (LV) dysfunction and cardiogenic shock. Extensive diagnostic work-up failed to reveal any structural heart disease. During electrophysiological study, AIVR originated from the right ventricular endocardial anterior wall and was successfully ablated using remote magnetic navigation. LV function showed complete recovery four weeks after the procedure. This case highlights a life-threatening evolution of an arrhythmia generally presented as a benign entity in children.


Subject(s)
Accelerated Idioventricular Rhythm/surgery , Catheter Ablation , Child , Humans , Male
5.
Food Chem Toxicol ; 44(7): 1108-13, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16487645

ABSTRACT

An herbal medicinal product (Exolise) containing as active ingredient an hydro-alcoholic extract of green tea named AR25 (standardized to 25% catechins) has been implicated in hepatic failures, leading to the withdrawal of the marketing authorization. The active ingredient of Exolise being manufactured with 80% ethanol, the question to know whether the extraction solvent could introduce some toxic components was hypothesized. Two investigations were conducted in Wistar rats to determine if repeated oral administration of different green tea extracts could corroborate the reported hepatotoxicity in humans. In a preliminary 6 week-study, experimental groups (n=9/group) received either the vehicle or a methylene chloride extract (2500 mg/kg body weight) where potential non-polar hepatotoxin(s) could be concentrated. In a second experiment (12 week-study), rats were divided in three groups (n=10/group) and treated with either the vehicle, or an aqueous extract (1400 mg/kg) or AR25 green tea extract (2000 mg/kg). Rat liver functions were assessed by serum biochemistry of hepatotoxicity markers. No sign of evidence of characteristic hepatotoxicity was found in rats treated with very high amount of different green tea extracts in these two experiments (respectively a daily dosage, which was about 900 and 80 times higher to the therapeutic daily dosage of Exolise.


Subject(s)
Liver/drug effects , Tea/chemistry , Animals , Chemical and Drug Induced Liver Injury/enzymology , Enzymes/blood , Female , Liver Function Tests , Plant Extracts/chemistry , Plant Extracts/pharmacology , Rats , Rats, Wistar
6.
J Clin Pharm Ther ; 28(5): 403-8, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14632965

ABSTRACT

Various studies suggested that cytotoxicity induced by 5-fluorouracil (5-FU) is an apoptotic mechanism possibly mediated by the Fas/FasL system. In this preliminary work, we studied retrospectively the role the Fas/FasL expression as a predictive response factor with fluoropyrimidine-based chemotherapies. We developed a real-time PCR method for measuring Fas and FasL expression in various biopsies from patients treated with a FUFOL-like protocol. No correlation was found between Fas or FasL expression and overall survival or partial response. However, the PCR assay was simple and convenient to use for quantitation of Fas/FasL in tumor biopsies.


Subject(s)
Antimetabolites, Antineoplastic/therapeutic use , Apoptosis/drug effects , Colonic Neoplasms/drug therapy , Fluorouracil/therapeutic use , Membrane Glycoproteins/metabolism , Adult , Aged , Antimetabolites, Antineoplastic/adverse effects , Colonic Neoplasms/mortality , Colonic Neoplasms/pathology , DNA, Complementary/genetics , Fas Ligand Protein , Female , Fluorouracil/adverse effects , Humans , Liver Neoplasms/secondary , Male , Middle Aged , Polymerase Chain Reaction , Prognosis , Retrospective Studies
7.
J Chemother ; 15(3): 266-74, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12868554

ABSTRACT

The human liver metabolism of paclitaxel (Taxol), an anticancer drug, leads to three metabolites: 6alpha-hydroxypaclitaxel, 3'-p-hydroxypaclitaxel and 6alpha,3'-p-dihydroxypaclitaxel. The inter-individual variability of paclitaxel metabolism was investigated first in vitro using 22 human liver microsomes. Three metabolites have been detected by HPLC. This preliminary work revealed marked inter-individual differences in paclitaxel metabolism. The amount of major metabolite 6alpha-hydroxypaclitaxel formed varied 16-fold (0.7 to 11.5 nmol/mg/h). We next studied the effect of 29 compounds (antineoplastics, antiemetics, histamine-2 receptor antagonist, antalgics, antifungals, antivirals, psychotropics, antibiotic, corticoid, antiarrhythmic, calcium channel blocker) on paclitaxel metabolism in human liver microsomes. Among the compounds studied, quercetin, antifungal drugs such as ketoconazole and miconazole, and the antineoplastic drug doxorubicin inhibited formation of 6alpha-hydroxypaclitaxel. Dixon plots indicated that quercetin and doxorubicin inhibited 6alpha-hydroxypaclitaxel formation through a competitive mechanism with a Ki of 10.1 microM and 64.8 microM, respectively. The inhibition of this metabolite by ketoconazole was through a noncompetitive mechanism with a Ki of 11.8 microM. Our data thus suggest that special attention should be paid when these drugs are combined in clinical practice.


Subject(s)
Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Microsomes, Liver/drug effects , Paclitaxel/metabolism , Paclitaxel/pharmacology , Adult , Biological Availability , Cells, Cultured , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Drug Interactions , Female , Humans , Male , Observer Variation , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...